Pseudoexfoliation (PEX) syndrome is a generalized disorder of the extracellular matrix and an important risk factor for secondary open-angle glaucoma.
1,2 The disease is characterized by deposition of abnormal microfibrillar aggregates on ocular tissues lining the aqueous-bathed surfaces of the anterior segment.
2 The origin of PEX material is unclear, but it is believed to be multifocally produced by several ocular tissues, including the iris, lens epithelium, nonpigmented ciliary epithelium, trabecular meshwork, and corneal endothelium.
3 In addition to the eye, extraocular tissues such as skin, lung, liver, cerebral meninges, kidney, blood vessels, and gallbladder exhibit the presence of the abnormal PEX material.
4-7 Pseudoexfoliation syndrome exhibits an age-related incidence and worldwide prevalence that varies markedly among different ethnic groups, from being virtually absent in Greenland Eskimos to affecting 20% to 25% of individuals in Iceland and Finland.
8-10 In a rural South Indian population older than 40 years, the prevalence of PEX syndrome is 6%.
11 The cause of PEX syndrome and the molecular components of PEX materials are unclear, but several studies in recent years have shed light on the pathogenesis of PEX syndrome at genetic and protein levels. Thorleifsson et al
12 performed a genome-wide association study in cases and controls from Icelandic and Swedish populations to identify the genetic factors associated with the increased risk of PEX syndrome. The study identified a strong association between PEX syndrome and glaucoma and 3 single-nucleotide polymorphisms (SNPs) in the lysyl oxidase–like 1 (
LOXL1; OMIM:153456) gene. An extracellular copper-dependent monoamine oxidase, LOXL1 is involved in covalent cross-linking of collagen and elastin through oxidative deamination of lysine or hydroxylysine residues.
13,14 Of the SNPs identified by Thorleifsson et al,
12 2 mapped to exon1 (rs1048661 [R141L] and rs3825942 [G153D]), causing missense changes at the N-terminal part of the protein; the third SNP (rs2165241) mapped to the first intron of
LOXL1. The study demonstrated that the 2 nonsynonymous SNPs of
LOXL1 can account for more than 99% of all PEX cases (ie, syndrome and glaucoma).
12 Subsequently, these findings were replicated in multiple populations globally, which established
LOXL1 as a major genetic risk factor for PEX syndrome and glaucoma.
15-33